GABRG2 and developmental and epileptic encephalopathy: The phenotypic spectrum of GABRG2 variants extends to the pharmacoresistant epilepsies, including Dravet syndrome and developmental epileptic encephalopathies (DEEs) (Harkin et al., 2002; Shen et al., 2017; Oyrer et al., 2018).